Ownership history in Commodore Capital LP · 10 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in SOLENO THERAPEUTICS INC (SLNO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,200,000 | -150,000 | -11.1% | 3.70% | $55.6M | $46.30 |
| 2025 Q3 | ADDED | 1,350,000 | +740,000 | +121.3% | 4.46% | $91.3M | $67.60 |
| 2025 Q2 | REDUCED | 610,000 | -540,000 | -47.0% | 3.61% | $51.1M | $83.78 |
| 2025 Q1 | REDUCED | 1,150,000 | -375,000 | -24.6% | 6.05% | $82.2M | $71.45 |
As of 2025 Q4 — sorted by position size